Company
Osivax
Pioneering a New Class of Vaccines against Global Unmet Medical Needs
Also known as OSIVAX SAS
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Lyon, France
- Founded
- 2017
- Legal name
- OSIVAX SAS
- osivax.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Osivax is leveraging its oligoDOM TM self-assembling nanoparticles platform technology to develop universal vaccines against constantly mutating pathogens.
Products
- Other
- OVX836
Loading relationship preview